1. Exploring receptor tyrosine kinases-inhibitors in Cancer treatments, Egypt;Metibemu;J. Med. Hum. Genet.,2019
2. Pazopanib in metastatic renal Cancer: a “real-world” experience at National Cancer Institute “Fondazione G. Pascale”;Cecere;Front. Pharmacol.,2016
3. Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study;Kido;Int. J. Clin. Oncol.,2021
4. Pazopanib;Keisner;Drugs,2011
5. Revisiting electrochemical biosensing in the 21st century society for inflammatory cytokines involved in autoimmune, neurodegenerative, cardiac, viral and cancer diseases;Campuzano;Sensors (Switzerland),2021